Patient Outcomes and Cost Effects of Medicaid Formulary Restrictions on Antidepressants

Q3 Economics, Econometrics and Finance

Forum for Health Economics and Policy Pub Date : 2014-09-01 DOI:10.1515/fhep-2014-0016

S. Seabury, D. Lakdawalla, D. Walter, J. Hayes, T. Gustafson, A. Shrestha, D. Goldman

引用次数: 6

Abstract

Abstract Many state Medicaid programs have implemented policies designed to reduce spending on prescription drugs by restricting access to branded products. For patients with major depressive disorder, formulary restrictions could severely limit access to antidepressant therapies and disrupt care. We linked data on patient outcomes and spending from 24 state Medicaid programs to information on formulary restrictions from 2001 to 2008. Outcomes included frequency of MDD-related hospitalizations and ER visits per patient and total healthcare spending. We estimated the effect of the policies on patient outcomes and spending using a difference-and-difference approach. We found that restricting access to antidepressants increased the probability of an MDD-related hospitalization by 1.7 percentage points (16.6%). Furthermore, we found no evidence that these restrictions resulted in any net savings for Medicaid.

查看原文本刊更多论文

医疗补助限制抗抑郁药的患者结局和成本效应

许多州的医疗补助计划已经实施了旨在通过限制获得品牌产品来减少处方药支出的政策。对于重度抑郁症患者，处方限制可能严重限制获得抗抑郁治疗并扰乱护理。我们将2001年至2008年24个州医疗补助计划的患者结果和支出数据与处方限制信息联系起来。结果包括与mdd相关的住院次数和每个患者的急诊次数以及总医疗支出。我们使用差异和差异方法估计了政策对患者结果和支出的影响。我们发现限制抗抑郁药的使用使mdd相关住院的概率增加了1.7个百分点(16.6%)。此外，我们没有发现任何证据表明这些限制导致了医疗补助的净节省。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Forum for Health Economics and Policy Economics, Econometrics and Finance-Economics, Econometrics and Finance (miscellaneous)

CiteScore

1.60

自引率

0.00%

发文量

期刊介绍： Forum for Health Economics & Policy (FHEP) showcases articles in key substantive areas that lie at the intersection of health economics and health policy. The journal uses an innovative structure of forums to promote discourse on the most pressing and timely subjects in health economics and health policy, such as biomedical research and the economy, and aging and medical care costs. Forums are chosen by the Editorial Board to reflect topics where additional research is needed by economists and where the field is advancing rapidly. The journal is edited by Katherine Baicker, David Cutler and Alan Garber of Harvard University, Jay Bhattacharya of Stanford University, Dana Goldman of the University of Southern California and RAND Corporation, Neeraj Sood of the University of Southern California, Anup Malani and Tomas Philipson of University of Chicago, Pinar Karaca Mandic of the　University of Minnesota, and John Romley of the University of Southern California. FHEP is sponsored by the Schaeffer Center for Health Policy and Economics at the University of Southern California. A subscription to the journal also includes the proceedings from the National Bureau of Economic Research''s annual Frontiers in Health Policy Research Conference. Topics: Economics, Political economics, Biomedical research and the economy, Aging and medical care costs, Nursing, Cancer studies, Medical treatment, Others related.